{"disease":{"id":"allergens","name":"allergens"},"drugs":{"marketed":[{"drug_id":"histamine","indication_name":"Hyposensitization to allergens","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eramin","generic_name":"HISTAMINE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Histamine H3 receptor","drug_class":"histamine","quality_score":44,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04729517","title":"Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Abdi Ibrahim Ilac San. ve Tic A.S.","has_results":false},{"nct_id":"NCT00341445","title":"Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes: A Randomized Control Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}